The interaction of neutrophils with respiratory epithelial cells in viral infection

S Z Wang1, K D Forsyth

  • 1Department of Paediatrics, Flinders Medical Centre, Bedford Park, South Australia, Australia.

Respirology (Carlton, Vic.)
|March 23, 2000
PubMed

Insights

Respiratory syncytial virus (RSV) bronchiolitis involves neutrophils, which contribute to airway damage. Targeting neutrophil activity may offer a new clinical therapy for this common childhood viral infection.

Area of Science:

  • Immunology
  • Pediatrics
  • Respiratory Medicine

Background:

  • Respiratory syncytial virus (RSV) is a common viral infection affecting nearly all children by age two.
  • RSV is the leading cause of bronchiolitis, a condition frequently associated with childhood asthma.
  • The precise mechanisms driving RSV bronchiolitis pathophysiology remain incompletely understood.

Purpose of the Study:

  • To elucidate the role of neutrophils in the pathophysiology of RSV bronchiolitis.
  • To explore the mechanisms by which neutrophils contribute to airway inflammation and damage during RSV infection.
  • To identify potential therapeutic targets for mitigating neutrophil-induced epithelial damage in viral respiratory infections.

Main Methods:

  • Review of current evidence on neutrophil involvement in viral infections, particularly RSV.
  • Analysis of neutrophil chemoattractant production, adhesion molecule expression, and epithelial cell interactions.
  • Examination of neutrophil apoptosis as a regulatory mechanism in RSV infection.

Main Results:

  • Viral infections, including RSV, increase neutrophil chemoattractant production, leading to migration into airways.
  • Up-regulation of adhesion molecules enhances neutrophil-epithelial cell binding and contributes to epithelial damage.
  • Neutrophils augment viral-induced epithelial damage and detachment, playing a key role in disease pathophysiology.
  • Increased neutrophil apoptosis in RSV infection may serve as an endogenous mechanism to limit tissue damage.

Conclusions:

  • Neutrophils are critical players in the pathophysiology of viral respiratory infections like RSV bronchiolitis.
  • Therapeutic strategies aimed at inhibiting neutrophil chemoattractants, adhesion molecules, or proteases could prevent neutrophil-induced epithelial damage.
  • Interventions targeting neutrophil-mediated damage present a promising avenue for clinical therapy in RSV and other viral infections.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes01:27

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...